{"pmid":32300370,"pmcid":"PMC7148425","title":"Can an effective SARS-CoV-2 vaccine be developed for the older population?","text":["Can an effective SARS-CoV-2 vaccine be developed for the older population?","The emergence of SARS-CoV-2 and its inordinately rapid spread is posing severe challenges to the wellbeing of millions of people worldwide, health care systems and the global economy. While many younger people experience no or mild symptoms on infection, older adults are highly susceptible to life-threatening respiratory and systemic conditions which demand a full understanding and leveraging of knowledge of the differences between immunity in young and old people. Consequently, we welcome papers addressing any issues relevant to immunity and ageing in the context of SARS-CoV-2, and will endeavour to fast-track peer-review. We aim to provide a platform exclusively for discussions of individual and age differences in susceptibility and immune responses to COVID caused by SARS-CoV-2 infection and how to prevent or reduce severity of disease in older adults.","Immun Ageing","Pawelec, Graham","Weng, Nan-Ping","32300370"],"abstract":["The emergence of SARS-CoV-2 and its inordinately rapid spread is posing severe challenges to the wellbeing of millions of people worldwide, health care systems and the global economy. While many younger people experience no or mild symptoms on infection, older adults are highly susceptible to life-threatening respiratory and systemic conditions which demand a full understanding and leveraging of knowledge of the differences between immunity in young and old people. Consequently, we welcome papers addressing any issues relevant to immunity and ageing in the context of SARS-CoV-2, and will endeavour to fast-track peer-review. We aim to provide a platform exclusively for discussions of individual and age differences in susceptibility and immune responses to COVID caused by SARS-CoV-2 infection and how to prevent or reduce severity of disease in older adults."],"journal":"Immun Ageing","authors":["Pawelec, Graham","Weng, Nan-Ping"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32300370","week":"202016|Apr 13 - Apr 19","doi":"10.1186/s12979-020-00180-2","keywords":["covid","immunosenescence","sars-cov-2","severe acute respiratory syndrome","vaccination"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664357978654900224,"score":8.233237,"similar":[{"pmid":32273490,"title":"Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?","text":["Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?","Pediatric coronavirus disease - 19 (COVID-19) infection is relatively mild when compared to adults, and children are reported to have a better prognosis. Mortality in children appears rare. Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute to transmission. It remains unclear why children and young adults are less severely affected than older individuals, but this might involve differences in immune system function in the elderly and/or differences in the expression/function of the cellular receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Angiotensin converting enzyme 2 (ACE2). Laboratory findings and chest imaging may not be specific in children with COVID-19. Diagnosis is by Reverse transcriptase-Polymerase chain reaction (RT-PCR) testing of upper or lower respiratory tract secretions. This review additionally considers COVID-19 in immunosuppressed children, and also suggests a management algorithm for the few children who appear to present with life threatening infection, including the potential use of antiviral and immunomodulatory treatment. The most significant threat to global child health from SARS-CoV-2 is unlikely to be related to COVID 19 in children, but rather the socio-economic consequences of a prolonged pandemic.","Indian Pediatr","Balasubramanian, S","Rao, Neha Mohan","Goenka, Anu","Roderick, Marion","Ramanan, Athimalaipet V","32273490"],"abstract":["Pediatric coronavirus disease - 19 (COVID-19) infection is relatively mild when compared to adults, and children are reported to have a better prognosis. Mortality in children appears rare. Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute to transmission. It remains unclear why children and young adults are less severely affected than older individuals, but this might involve differences in immune system function in the elderly and/or differences in the expression/function of the cellular receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Angiotensin converting enzyme 2 (ACE2). Laboratory findings and chest imaging may not be specific in children with COVID-19. Diagnosis is by Reverse transcriptase-Polymerase chain reaction (RT-PCR) testing of upper or lower respiratory tract secretions. This review additionally considers COVID-19 in immunosuppressed children, and also suggests a management algorithm for the few children who appear to present with life threatening infection, including the potential use of antiviral and immunomodulatory treatment. The most significant threat to global child health from SARS-CoV-2 is unlikely to be related to COVID 19 in children, but rather the socio-economic consequences of a prolonged pandemic."],"journal":"Indian Pediatr","authors":["Balasubramanian, S","Rao, Neha Mohan","Goenka, Anu","Roderick, Marion","Ramanan, Athimalaipet V"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32273490","week":"202015|Apr 06 - Apr 12","source":"PubMed","topics":["Treatment","Diagnosis","Mechanism","Transmission"],"weight":1,"_version_":1663712077842219008,"score":168.16238},{"pmid":32274617,"title":"SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes.","text":["SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes.","SARS-CoV-2 virus, the causative agent of the coronavirus infectious disease-19 (COVID-19), is taking the globe by storm, approaching 500,000 confirmed cases and over 21,000 deaths as of March 25, 2020. While under control in some affected Asian countries (Taiwan, Singapore, Vietnam), the virus demonstrated an exponential phase of infectivity in several large countries (China in late January and February and many European countries and the USA in March), with cases exploding by 30-50,000/day in the third and fourth weeks of March, 2020. SARS-CoV-2 has proven to be particularly deadly to older adults and those with certain underlying medical conditions, many of whom are of advanced age. Here, we briefly review the virus, its structure and evolution, epidemiology and pathogenesis, immunogenicity and immune, and clinical response in older adults, using available knowledge on SARS-CoV-2 and its highly pathogenic relatives MERS-CoV and SARS-CoV-1. We conclude by discussing clinical and basic science approaches to protect older adults against this disease.","Geroscience","Nikolich-Zugich, Janko","Knox, Kenneth S","Rios, Carlos Tafich","Natt, Bhupinder","Bhattacharya, Deepta","Fain, Mindy J","32274617"],"abstract":["SARS-CoV-2 virus, the causative agent of the coronavirus infectious disease-19 (COVID-19), is taking the globe by storm, approaching 500,000 confirmed cases and over 21,000 deaths as of March 25, 2020. While under control in some affected Asian countries (Taiwan, Singapore, Vietnam), the virus demonstrated an exponential phase of infectivity in several large countries (China in late January and February and many European countries and the USA in March), with cases exploding by 30-50,000/day in the third and fourth weeks of March, 2020. SARS-CoV-2 has proven to be particularly deadly to older adults and those with certain underlying medical conditions, many of whom are of advanced age. Here, we briefly review the virus, its structure and evolution, epidemiology and pathogenesis, immunogenicity and immune, and clinical response in older adults, using available knowledge on SARS-CoV-2 and its highly pathogenic relatives MERS-CoV and SARS-CoV-1. We conclude by discussing clinical and basic science approaches to protect older adults against this disease."],"journal":"Geroscience","authors":["Nikolich-Zugich, Janko","Knox, Kenneth S","Rios, Carlos Tafich","Natt, Bhupinder","Bhattacharya, Deepta","Fain, Mindy J"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32274617","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s11357-020-00186-0","keywords":["COVID-19","Care","Immunity","Older adults","Pathogenesis","SARS-CoV-2"],"source":"PubMed","locations":["China","Singapore","Vietnam","China","USA"],"countries":["United States","China","Viet Nam","Singapore"],"countries_codes":["USA|United States","CHN|China","VNM|Viet Nam","SGP|Singapore"],"topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1663712077878919169,"score":162.43285},{"pmid":32283450,"pmcid":"PMC7146665","title":"Unprecedented disruption of lives and work: Health, distress and life satisfaction of working adults in China one month into the COVID-19 outbreak.","text":["Unprecedented disruption of lives and work: Health, distress and life satisfaction of working adults in China one month into the COVID-19 outbreak.","We assess the health and wellbeing of normal adults living and working after one month of confinement to contain the COVID-19 outbreak in China. On Feb 20-21, 2020, we surveyed 369 adults in 64 cities in China that varied in their rates of confirmed coronavirus cases on their health conditions, distress and life satisfaction. 27% of the participants worked at the office, 38% resorted to working from home, and 25% stopped working due to the outbreak. Those who stopped working reported worse mental and physical health conditions as well as distress. The severity of COVID-19 in an individual's home city predicts their life satisfaction, and this relationship is contingent upon individuals' existing chronic health issues and their hours of exercise. Our evidence supports the need to pay attention to the health of people who were not infected by the virus, especially for people who stopped working during the outbreak. Our results highlight that physically active people might be more susceptible to wellbeing issues during the lockdown. Policymakers who are considering introducing restrictive measures to contain COVID-19 may benefit from understanding such health and wellbeing implications.","Psychiatry Res","Zhang, Stephen X","Wang, Yifei","Rauch, Andreas","Wei, Feng","32283450"],"abstract":["We assess the health and wellbeing of normal adults living and working after one month of confinement to contain the COVID-19 outbreak in China. On Feb 20-21, 2020, we surveyed 369 adults in 64 cities in China that varied in their rates of confirmed coronavirus cases on their health conditions, distress and life satisfaction. 27% of the participants worked at the office, 38% resorted to working from home, and 25% stopped working due to the outbreak. Those who stopped working reported worse mental and physical health conditions as well as distress. The severity of COVID-19 in an individual's home city predicts their life satisfaction, and this relationship is contingent upon individuals' existing chronic health issues and their hours of exercise. Our evidence supports the need to pay attention to the health of people who were not infected by the virus, especially for people who stopped working during the outbreak. Our results highlight that physically active people might be more susceptible to wellbeing issues during the lockdown. Policymakers who are considering introducing restrictive measures to contain COVID-19 may benefit from understanding such health and wellbeing implications."],"journal":"Psychiatry Res","authors":["Zhang, Stephen X","Wang, Yifei","Rauch, Andreas","Wei, Feng"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283450","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.psychres.2020.112958","keywords":["2019-nCoV","Coronavirus","Early evidence","Exercising hours","Life disruptions","Mental health","Physical health"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664182200759746560,"score":147.67671},{"pmid":32283324,"pmcid":"PMC7151358","title":"COVID-19 - Considerations for the paediatric rheumatologist.","text":["COVID-19 - Considerations for the paediatric rheumatologist.","The novel coronavirus SARS-CoV2 is a threat to the health and well-being of millions of lifes across the globe. A significant proportion of adult patients require hospitalisation and may develop severe life-threatening complications. Children, on the other hand, can carry and transmit the virus, but usually do not develop severe disease. Mortality in the paediatric age-group is relatively low. Differences in virus containment and clearance, as well as reduced inflammation-related tissue and organ damage may be caused by age-specific environmental and host factors. Since severe complications in adults are frequently caused by uncontrolled immune responses and a resulting \"cytokine storm\" that may be controlled by targeted blockade of cytokines, previously established treatment with immunosuppressive treatments may indeed protect children from complications.","Clin Immunol","Hedrich, Christian M","32283324"],"abstract":["The novel coronavirus SARS-CoV2 is a threat to the health and well-being of millions of lifes across the globe. A significant proportion of adult patients require hospitalisation and may develop severe life-threatening complications. Children, on the other hand, can carry and transmit the virus, but usually do not develop severe disease. Mortality in the paediatric age-group is relatively low. Differences in virus containment and clearance, as well as reduced inflammation-related tissue and organ damage may be caused by age-specific environmental and host factors. Since severe complications in adults are frequently caused by uncontrolled immune responses and a resulting \"cytokine storm\" that may be controlled by targeted blockade of cytokines, previously established treatment with immunosuppressive treatments may indeed protect children from complications."],"journal":"Clin Immunol","authors":["Hedrich, Christian M"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283324","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.clim.2020.108420","keywords":["ARDS","COVID","Cytokine storm","Inflammation","Paediatric","Rheumatology","SARS","SARS-CoV2"],"source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1664182200833146880,"score":141.65178},{"pmid":32294922,"title":"Benefits of Exercise on Influenza or Pneumonia in Older Adults: A Systematic Review.","text":["Benefits of Exercise on Influenza or Pneumonia in Older Adults: A Systematic Review.","A coronavirus pandemic has recently become one of the greatest threats the world is facing. Older adults are under a high risk of infection because of weaker immune systems. Therefore, the purpose of this review is to summarize the recent scientific evidence that outlines the effects of exercise on influenza or pneumonia in older adults. An electronic literature search was conducted using the WEB OF SCIENCE, SCIENCEDIRECT and GOOGLE SCHOLAR databases using the following keywords, \"Exercise,\" \"Older adult,\" \"Influenza,\" and \"Pneumonia.\" Any randomized control trials, cross-sectional and observational studies that related to this topic were all included. Twenty studies met the eligibility criteria for this review. Thirteen randomized control trials investigated the effects of exercise on the immune responses to influenza or pneumonia vaccination: seven trials employed moderate aerobic exercise, three employed resistance exercise, and the remaining three used Asian martial arts or special home-based exercises. Five cross-sectional and two observational studies examined the associations between exercise/physical condition and influenza/pneumonia. Most of the current studies suggested that prolonged moderate aerobic exercise may help to reduce the risk of influenza-related infection and improve the immune responses to influenza or pneumonia vaccination in older adults. In addition, training in traditional Asian martial arts was also found to be beneficial. Future research should focus on the different effects of moderate and vigorous exercise on influenza-related diseases.","Int J Environ Res Public Health","Song, Yang","Ren, Feng","Sun, Dong","Wang, Meizi","Baker, Julien S","Istvan, Biro","Gu, Yaodong","32294922"],"abstract":["A coronavirus pandemic has recently become one of the greatest threats the world is facing. Older adults are under a high risk of infection because of weaker immune systems. Therefore, the purpose of this review is to summarize the recent scientific evidence that outlines the effects of exercise on influenza or pneumonia in older adults. An electronic literature search was conducted using the WEB OF SCIENCE, SCIENCEDIRECT and GOOGLE SCHOLAR databases using the following keywords, \"Exercise,\" \"Older adult,\" \"Influenza,\" and \"Pneumonia.\" Any randomized control trials, cross-sectional and observational studies that related to this topic were all included. Twenty studies met the eligibility criteria for this review. Thirteen randomized control trials investigated the effects of exercise on the immune responses to influenza or pneumonia vaccination: seven trials employed moderate aerobic exercise, three employed resistance exercise, and the remaining three used Asian martial arts or special home-based exercises. Five cross-sectional and two observational studies examined the associations between exercise/physical condition and influenza/pneumonia. Most of the current studies suggested that prolonged moderate aerobic exercise may help to reduce the risk of influenza-related infection and improve the immune responses to influenza or pneumonia vaccination in older adults. In addition, training in traditional Asian martial arts was also found to be beneficial. Future research should focus on the different effects of moderate and vigorous exercise on influenza-related diseases."],"journal":"Int J Environ Res Public Health","authors":["Song, Yang","Ren, Feng","Sun, Dong","Wang, Meizi","Baker, Julien S","Istvan, Biro","Gu, Yaodong"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32294922","week":"202016|Apr 13 - Apr 19","doi":"10.3390/ijerph17082655","keywords":["exercise","influenza","older adults","pneumonia"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Pneumonia"],"_version_":1664266651320713216,"score":132.24782}]}